Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers

Ash SY, Harmouche R, Putman RK, Ross JC, Diaz AA, Hunninghake GM, Onieva JO, Martinez FJ, Choi AM, Lynch DA, et al. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest. 2017;152(4):780–791.

Abstract

BACKGROUND: Smoking-related lung injury may manifest on CT scans as both emphysema and interstitial changes. We have developed an automated method to quantify interstitial changes and hypothesized that this measurement would be associated with lung function, quality of life, mortality, and a mucin 5B (MUC5B) polymorphism. METHODS: Using CT scans from the Genetic Epidemiology of COPD Study, we objectively labeled lung parenchyma as a tissue subtype. We calculated the percentage of the lung occupied by interstitial subtypes. RESULTS: A total of 8,345 participants had clinical and CT scanning data available. A 5% absolute increase in interstitial changes was associated with an absolute decrease in FVC % predicted of 2.47% (P  .001) and a 1.36-point higher St. George’s Respiratory Questionnaire score (P  .001). Among the 6,827 participants with mortality data, a 5% increase in interstitial changes was associated with a 29% increased risk of death (P 
Last updated on 02/26/2023